The dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression
about
Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic ReviewEmerging treatments in alopecia.Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor SyndromeThe role of HOXC6 in prostate cancer development.Men With Severe Lower Urinary Tract Symptoms Are at Increased Risk of DepressionEarly dutasteride monotherapy in men with detectable serum prostate-specific antigen levels following radical prostatectomy: A prospective trial.Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?Impact of prostate volume on erectile dysfunction and premature ejaculation.Risk of Incident Antidepressant-Treated Depression Associated with Use of 5α-Reductase Inhibitors Compared with Use of α-Blockers in Men with Benign Prostatic Hyperplasia: A Population-Based Study Using the Clinical Practice Research Datalink.GR3027 antagonizes GABAA receptor-potentiating neurosteroids and restores spatial learning and motor coordination in rats with chronic hyperammonemia and hepatic encephalopathy.Protective Effects of Lepidium meyenii (Maca) Aqueous Extract and Lycopene on Testosterone Propionate-Induced Prostatic Hyperplasia in Mice.Assessment of tissue levels of dickkopf-1 in androgenetic alopecia and alopecia areata.Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia.Safety and efficacy of a novel Prunus domestica extract (Sitoprin, CR002) on testosterone-induced benign prostatic hyperplasia (BPH) in male Wistar rats.
P2860
Q28069186-5B34D907-97F1-4469-B6AC-8BE832074D67Q34444226-1431254C-D105-486D-8E6D-C72B3FFEF9B2Q34552026-DF124C32-DD8D-4D7C-83E2-D23FE11C14E3Q35756663-3C90F14E-20A8-487C-BC23-545C2D4176E6Q36438266-A6023021-9A19-4CD2-94DB-0405C8DC6C43Q37671710-EC2EA94D-14FB-4443-81D7-036332CCF470Q38571198-DF678A7D-01D5-44FB-8BA9-E3B4B5C6D0D9Q38871627-DA162830-DA11-48FC-A3BD-B12D40DEC8EBQ38906881-B5672D3F-AF33-49F2-912E-2704025BFB53Q43039942-9EA62A06-0FA3-442E-8C16-D0389B70D565Q46350450-737F61C5-66BB-4483-818B-3E9EA5873335Q46593792-EEABA06A-E346-483F-B918-BA84D3EAC806Q47102773-10B7B73D-5666-4629-9E4B-091EEC38CE46Q47596977-157BC7D9-D1A0-41B3-923B-047862294559Q49980853-FE4CF98A-280B-42B5-9FDE-B1DE1E0CA7CB
P2860
The dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The dark side of 5α-reductase ...... prostate cancer and depression
@ast
The dark side of 5α-reductase ...... prostate cancer and depression
@en
The dark side of 5α-reductase ...... prostate cancer and depression
@nl
type
label
The dark side of 5α-reductase ...... prostate cancer and depression
@ast
The dark side of 5α-reductase ...... prostate cancer and depression
@en
The dark side of 5α-reductase ...... prostate cancer and depression
@nl
prefLabel
The dark side of 5α-reductase ...... prostate cancer and depression
@ast
The dark side of 5α-reductase ...... prostate cancer and depression
@en
The dark side of 5α-reductase ...... prostate cancer and depression
@nl
P2093
P2860
P1476
The dark side of 5α-reductase ...... prostate cancer and depression
@en
P2093
Abdulmaged M Traish
Ashwini Mulgaonkar
Nicholas Giordano
P2860
P304
P356
10.4111/KJU.2014.55.6.367
P407
P577
2014-06-01T00:00:00Z